10 October 2016
Tackling antimicrobial resistance crisis - what roles will regulation and innovation play?
Organised by:
UK Members of the European Federation of Biotechnology (SCI, Biochemical Society, Microbiological Society, Society for Applied Microbiology and the Royal Society of Biology) in association with the Learned Society Partnership on AMR
Royal Society of Biology, London, UK
Registration Closed
This event is no longer available for registration.
Share this event
Synopsis
This Policy Lates event will examine the roles of innovation and regulation in tackling the AMR crisis from different perspectives, including veterinary research, biotechnology and public health.
Earlier this year, a review of antimicrobial resistance (AMR) by Lord Jim O'Neill set out a comprehensive action plan for the world to prevent the spread of infectious diseases, develop new rapid diagnostic tools and incentivise research into new antibiotics.
According to the report, if not tackled urgently, antimicrobial resistance could kill 10 million people a year by 2050, the equivalent of 1 person every 3 seconds; more than cancer kills today.
Venue and Contact
Society of Biology
Charles Darwin House
12 Roger Street
London, WC1N 2JU
Gabriel Butkute
Tel: +44 (0)20 7598 1561
Email: gabriele.butkute@rsb.org.uk
Fees
The event is FREE to attend.
Become an SCI Member and save on this and future events
See Membership OptionsSign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking Process/Deadlines
CPD Info
SCI Members attending this meeting are able to claim CPD points.
Partners
Additional Info
Speakers
- Professor Jeff Cole, Vice President, European Federation of Biotechnology (Chair)
- John Broughall, Antibiotic Research UK
- Professor Mark Fielder, Kingston University
- Tamar Ghosh, Lead, Longitude Prize, Nesta
For general enquiries, please call:
Emma Thomas
Committee Support Contact for the SCI Biotechnology Group
T: 0207 598 1594